Clinical Trials List
2024-06-30 - 2029-06-30
Phase II
Recruiting8
ICD-10C15.9
Malignant neoplasm of esophagus, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9150.9
Malignant neoplasm of esophagus, unspecified
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Taiwan Multiple Center
-
Update
2026/05/16
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Chih-Chieh Yen Division of Hematology & Oncology
- Wei-Lun Chang 無
- 劉奕廷 Division of Hematology & Oncology
- Shang-Hung Chen 國衛院
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Ping Hung 無
- 唐振育 無
- 姜乃榕 無
- Tien-Hua Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
45 participants
